VACCINES - Patent 0939650

(19)

(11)

EP 0 939 650 A1

(12)

(43)	Date of publication:
	08.09.1999 Bulletin 1999/36

(21)	Application number: 97910430.0

(22)	Date of filing: 30.09.1997

(51)

International Patent Classification (IPC):

A61K 39/ 00^{( . )}
A61K 39/ 02^{( . )}
A61K 39/ 10^{( . )}
A61K 39/ 118^{( . )}
A61K 39/ 145^{( . )}
A61K 39/ 245^{( . )}
A61K 39/ 39^{( . )}
A61P 31/ 14^{( . )}
A61P 31/ 18^{( . )}
A61P 31/ 22^{( . )}
A61P 33/ 06^{( . )}

A61K 39/ 015^{( . )}
A61K 39/ 095^{( . )}
A61K 39/ 112^{( . )}
A61K 39/ 125^{( . )}
A61K 39/ 21^{( . )}
A61K 39/ 29^{( . )}
A61P 31/ 04^{( . )}
A61P 31/ 16^{( . )}
A61P 31/ 20^{( . )}
A61P 33/ 02^{( . )}
A61P 35/ 00^{( . )}

(86)	International application number:
	PCT/EP1997/005578

(87)	International publication number:
	WO 1998/015287 (16.04.1998 Gazette 1998/15)

(84)	Designated Contracting States:
	AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
	Designated Extension States:
	SI

(30)

Priority:

05.10.1996 GB 19960020795

(71)	Applicant: SMITHKLINE BEECHAM BIOLOGICALS S.A.
	1330 Rixensart (BE)

(72)	Inventors:
	GARCON, Nathalie, SmithKline Beecham Bio. S.A. B-1330 Rixensart (BE) FRIEDE, Martin, SmithKline Beecham Bio. S.A. B-1330 Rixensart (BE)

(74)	Representative: Dalton, Marcus Jonathan William, et al
	SmithKline Beecham plc Corporate Intellectual Property, Two New Horizons Court Brentford, Middlesex TW8 9EP Brentford, Middlesex TW8 9EP (GB)

(54)

VACCINES